Download Files:
ARN2966
SKU
HY-18292-10 mg
Category Reference compound
Tags Amyloid-β, Neurological Disease, Neuronal Signaling
$90 – $750
Products Details
Product Description
– ARN2966 is a potent, orally active and cross the blood-brain barrier amyloid precursor protein (APP) translation modulator. ARN2966 shows anti-Aß aggregation and neuroprotective properties. ARN2966 has the potential for the research of alzheimer’s disease[1].
Web ID
– HY-18292
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– C12H12N2O
References
– [1]yodeji Asuni, et al. An APP translation modulator ARN2966 reduces BETA-AMYLOID deposition and prevents memory deficits in ALZHEIMER’S DISEASE transgenic mice. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. 2012.
CAS Number
– 102212-26-0
Molecular Weight
– 200.24
Compound Purity
– 99.87
SMILES
– OC1=CC=CC=C1NCC2=NC=CC=C2
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– DMSO : 110 mg/mL (ultrasonic)
Target
– Amyloid-β
Pathway
– Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.